Intensive Care Medicine

, Volume 23, Issue 12, pp 1251–1257 | Cite as

Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass

Role of type of flow and protective effect of selective digestive decontamination
  • A. E. Martinez-Pellús
  • M. Bru
  • G. Seller
  • T. Fuentes
  • P. Merino
  • J. Canovas
  • J. Sapiña
  • J. Moro
Originals

Abstract

Objective: To evaluate the possible related factors to endotoxemia and cytokine activation during the ischemic phase of extracorporeal surgery, and the effect of selective digestive decontamination (SDD) as a preventive measure.

Design: Prospective, open, randomized trial.

Setting: Two multidisciplinary ICUs (tertitary care hospitals).

Patients: One hundred consecutive patients undergoing cardiopulmonary bypass (CPB), randomly allocated to two groups: gut decontamination (group I=50 cases) and controls (group II=50 cases).

Interventions: Preoperative administration of oral non-absorbable antibiotics (polymyxin E, tobramycin and amphotericin B) versus no administration.

Measurements and results: The assessment of decontamination by means of the bacteriologic control of rectal swabs. Determinations of gastric intramucosal pH (gastric pHi) and plasma endotoxin, tumor necrosis factor (TNF) and interleukin-6 (IL-6) before surgery and during the ischemic and reperfusion phases of bypass. Rectal aerobic Gram-negative bacilli (AGNB) were significantly reduced in the treated patients and in 56 % total eradication was achieved. Endotoxin, TNF and IL-6 plasma levels were significantly lower in this group. By contrast, both endotoxin and TNF/IL-6 levels and gastric pHi correlated with the type of surgical flow (pulsatile versus non-pulsatile).

Conclusions: SDD reduces the gut content of enterobacteria. This may explain the lower endotoxin and cytokine levels detected in decontaminated patients. In addition to SDD, the type of flow employed during bypass seems to influence endotoxemia and cystokine levels.

Key words

Endotoxin Cytokines Cardiopulmonary bypass Pulsatile flow Selective digestive decontamination Gut ischemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Thijs LG, Hack CE (1991) The orchestra of mediators in the pathogenesis of septic shock: A review. In: IL Vincent (ed) Update in intensive care and emergency medicine. Springer, Berlin New York, pp 232–247Google Scholar
  2. 2.
    Browin JM, Grosso MA (1989) Cytokines, sepsis and the surgeon. Surg Gynecol Obstet 169: 568–574Google Scholar
  3. 3.
    Fiddian-Green RG (1990) Gut mucosal ischemia during cardiac surgery. J Thorac Cardiovasc Surg 4: 389–399Google Scholar
  4. 4.
    Andersen LW, Landow L, Baek L, Jansen E, Baker S (1993) Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin and tumor necrosis factor concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 21: 210–217PubMedCrossRefGoogle Scholar
  5. 5.
    Andersen LM, Baeck L, Degn H, Ilchd J, Lasnik M, Rasmussen JP (1987) Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 93: 115–119PubMedGoogle Scholar
  6. 6.
    Rocke DA, Gaffin SL, Wells MT, Koen Y, Brock-Utine JG (1987) Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 93: 832–837PubMedGoogle Scholar
  7. 7.
    Oudemans-van Straaten HM, Jansen PGM, Te Velthuis H, Beenakkers ICM, Stoutenbeek CP, Van Deventer SJH, Sturk A, Eysman L, Wildevuur Ch RH (1996) Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia. Intensive Care Med 22: 294–300PubMedCrossRefGoogle Scholar
  8. 8.
    Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, and the Ha-IA sepsis study group (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324: 429–436PubMedGoogle Scholar
  9. 9.
    Pinsky MR, Vincent JL, Deviers J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest 103: 565–575PubMedCrossRefGoogle Scholar
  10. 10.
    Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, Pennington JE, Wherry JC (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor in patients with sepsis syndrome. JAMA 273: 934–941PubMedCrossRefGoogle Scholar
  11. 11.
    Stoutenbeek CP, Van Saene HKF, Miranda DR, Zandstra DF (1984) The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 10: 185–192PubMedCrossRefGoogle Scholar
  12. 12.
    Martinez-Pellüs AE, Merino P, Bru M, Conejero R, Seller G, Muñoz C, Fuentes T, Gonzalez G, Alvarez B (1993) Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 21: 1684–1691PubMedGoogle Scholar
  13. 13.
    Heard SO, Helsmoortel CM, Kent JC, Shahnarian A, Fink MP (1991) Gastric tonometry in healthy volunteers: effect of ranitidine on calculated intramural gastric pHi. Crit Care Med 19: 271–274PubMedCrossRefGoogle Scholar
  14. 14.
    Deitch EA (1990) The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 125: 403–404PubMedGoogle Scholar
  15. 15.
    Alexander JW, Boyce ST, Babcock GF, Gianotti L, Peck MD, Dunn DL, Pyles T, Childress Ch, Ash SK (1990) The process of bacterial translocation. Ann Surg 212: 496–501PubMedCrossRefGoogle Scholar
  16. 16.
    Van Saene JJM, Stoutenbeek CP, Van Saene HKF (1989) Significant reduction of faecal endotoxin pool by oral polymyxin E and tobramycin in human volunteers. In: JL Vincent (ed) Update in intensive care and emergency medicine. Springer, Berlin New York, pp 128–134Google Scholar
  17. 17.
    De Camp MM, Demling R (1988) Posttraumatic multisystem organ failure. JAMA 260: 530–534CrossRefGoogle Scholar
  18. 18.
    Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parrillo JE (1991) Endotoxemia in human septic shock. Chest 99 (1): 169–175PubMedCrossRefGoogle Scholar
  19. 19.
    Meyrick BO, Ryan VA, Brigham KL (1986) Direct effect of E Coli endotoxin on structure and permeability of pulmonary endothelial non-layers and the endothelial layer of intestinal explants. Am J Pathol 122: 140–155PubMedGoogle Scholar
  20. 20.
    Ohri SK, Somasundaram S, Koak Y, Macpherson A, Keogh BE, Taylos KM, Menzies IS, Bjarnason Y (1994) The effect of intestinal hypoperfusion on intestinal absorption and permeability during cardiopulmonary bypass. Gastroenterology 106: 318–323PubMedGoogle Scholar
  21. 21.
    Taylor KM (1989) Vasopressor release and multiple organ failure in cardiac surgery. In: Marston A, Bulkley GB, Fiddian-Green RG, et al. (eds) Splanchnic ischemia and multiple organ failure. Mosby, St Louis, pp 89–99Google Scholar
  22. 22.
    Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN (1992) Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 20: 1090–1096PubMedCrossRefGoogle Scholar
  23. 23.
    Baue AE (1993) The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients. Ann Thorac Surg 55: 822–829PubMedGoogle Scholar
  24. 24.
    Riddington DW, Venkatesh B, Boivin ChM, Bonser RS, Elliot TSJ, Marshall T, Mountford PJ, Bion JF (1996) Intestinal permeability, gastric intramucosa pH and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA 275: 1007–1012PubMedCrossRefGoogle Scholar
  25. 25.
    SDD trialist collaborative group (1993) Meta-analysis of randomized controlled trials on the effect of selective decontamination of the digestive tract. BMJ 307: 525–532CrossRefGoogle Scholar
  26. 26.
    Fox MA, Peterson S, Fabri BM, Van Saene HKF, Williets T (1991) Selective decontamination of the digestive tract in cardiac surgical patients. Crit Care Med 19: 1486–1490PubMedCrossRefGoogle Scholar
  27. 27.
    Basha M, Meyer GS, Kunkel SL, Strieter RM, Rivers ED, Popovich J (1991) Presence of tumor necrosis factor in humans undergoing cardiopulmonary resuscitation with return of spontaneous circulation. J Crit Care 6 (4): 185–189CrossRefGoogle Scholar
  28. 28.
    Michie HR, Manoque KR, Spriggs DR, Revhaug A, O’Dwyer S, Dinarello ChA, Cerami A, Wolf SM, Wilmore DN (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318: 1481–1486PubMedGoogle Scholar
  29. 29.
    Colleti LM, Remick DG, Burtch GD, Kunkel SL, Strieker RM, Campbell DA (1990) Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85: 1936–1943CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • A. E. Martinez-Pellús
    • 1
  • M. Bru
    • 1
  • G. Seller
    • 1
  • T. Fuentes
    • 2
  • P. Merino
    • 3
  • J. Canovas
    • 3
  • J. Sapiña
    • 4
  • J. Moro
    • 5
  1. 1.Intensive Care UnitHospital Universitario “Virgen de la Arrixaca”El Palmar MurciaSpain
  2. 2.Immunology LaboratoryHospital Universitario “Virgen de la Arrixaca”El Palmar, MurciaSpain
  3. 3.Intensive Care UnitHospital UniversitarioAlicanteSpain
  4. 4.Immunology LaboratoryHospital UniversitarioAlicanteSpain
  5. 5.Anesthesiology, DepartmentHospital UniversitarioAlicanteSpain

Personalised recommendations